These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 22004136)
1. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus. Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136 [TBL] [Abstract][Full Text] [Related]
2. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. Haasbach E; Droebner K; Vogel AB; Planz O J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570 [TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model. Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063 [TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621 [TBL] [Abstract][Full Text] [Related]
5. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes. Scagnolari C; Trombetti S; Soldà A; Selvaggi C; Monteleone K; Spano L; Pierangeli A; Clementi M; Turriziani O; Antonelli G J Interferon Cytokine Res; 2011 Jun; 31(6):475-9. PubMed ID: 21235413 [TBL] [Abstract][Full Text] [Related]
6. Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Kang YM; Song BM; Lee JS; Kim HS; Seo SH Arch Virol; 2011 May; 156(5):759-67. PubMed ID: 21234768 [TBL] [Abstract][Full Text] [Related]
7. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets. Hamelin ME; Baz M; Bouhy X; Beaulieu E; Dubé K; Mallett C; Boivin G Antivir Ther; 2011; 16(5):775-9. PubMed ID: 21817200 [TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo anti-influenza virus activity of ribavirin injection]. Gao RM; Li XQ; He WY; Jiang JD; Li YH Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection. Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612 [TBL] [Abstract][Full Text] [Related]
10. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009. Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971 [TBL] [Abstract][Full Text] [Related]
11. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. Van Hoeven N; Belser JA; Szretter KJ; Zeng H; Staeheli P; Swayne DE; Katz JM; Tumpey TM J Virol; 2009 Apr; 83(7):2851-61. PubMed ID: 19144714 [TBL] [Abstract][Full Text] [Related]
14. Altered pathogenicity for seasonal influenza virus by single reassortment of the RNP genes derived from the 2009 pandemic influenza virus. Hsieh EF; Lin SJ; Mok CK; Chen GW; Huang CH; Wang YC; Chen TC; Chen CJ; Ojcius DM; Shih SR J Infect Dis; 2011 Sep; 204(6):864-72. PubMed ID: 21849283 [TBL] [Abstract][Full Text] [Related]
15. Effects of TheraMax on influenza virus infections in cell culture and in mice. Smee DF; Hurst BL; Wong MH Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851 [TBL] [Abstract][Full Text] [Related]
17. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Pushko P; Kort T; Nathan M; Pearce MB; Smith G; Tumpey TM Vaccine; 2010 Jul; 28(30):4771-6. PubMed ID: 20470801 [TBL] [Abstract][Full Text] [Related]
18. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice. Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393 [TBL] [Abstract][Full Text] [Related]
19. Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera. Wu QF; Wang W; Dai XY; Wang ZY; Shen ZH; Ying HZ; Yu CH J Ethnopharmacol; 2012 Jan; 139(2):668-71. PubMed ID: 22193174 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo. Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]